DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/df98db/global_idiopathic) has announced the addition of the "Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2011" report to their offering.
Fore Pharma's latest report "Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2011" is an outline of all the key research and development (R&D) activities of the global idiopathic pulmonary fibrosis drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.
The information presented in this report can be used by executives for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the idiopathic pulmonary fibrosis drug market is thoroughly covered by company and licensee with the deal summary.
Key Topics Covered By "Global Idiopathic Pulmonary Fibrosis Drug Pipeline Capsule - 2011" include:
- Idiopathic Pulmonary Fibrosis: Overview
- Idiopathic Pulmonary Fibrosis Drug Pipeline Overview
- Idiopathic Pulmonary Fibrosis Phase 3 Clinical Trial Drug Pipeline Insights
- Idiopathic Pulmonary Fibrosis Phase 2 Clinical Trial Drug Pipeline Insights
- Idiopathic Pulmonary Fibrosis Phase 1 Clinical Trial Drug Pipeline Insights
- Idiopathic Pulmonary Fibrosis Preclinical Research Drug Pipeline Insights
- Idiopathic Pulmonary Fibrosis Drug Discovery Pipeline Insights
- Geographic Landscape of Idiopathic Pulmonary Fibrosis R&D Activities
- Idiopathic Pulmonary Fibrosis R&D Activities in North America
- Idiopathic Pulmonary Fibrosis R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Idiopathic Pulmonary Fibrosis Drug Market
For more information visit http://www.researchandmarkets.com/research/df98db/global_idiopathic